Kenan Turnacioglu is a General Partner at Catalio Capital Management, LP, where he also serves on the Public Equities and Nexus Investment Committees. He is also the Chairman of PaigeAI, a machine learning pathology company spun out of Memorial Sloan Kettering.
In 2011, Kenan co-founded PointState Capital, LP and managed the portfolios and investment teams in Healthcare and Consumer sectors, before departing in 2018. From 2001 to 2010, he worked at Duquesne Capital Management, LLC managing Healthcare investments. While at these positions he also served on the Boards of StemCentrx (2013-2016), Agensys (2004-2007), and NYU Langone Cancer Center (2010-2015). From 1998-2000, he worked at Credit Suisse as an analyst on the biotech team.
Kenan earned a B.A. from Rutgers University, and a Ph.D. from University of Pennsylvania, before becoming a Post-Doctoral Fellow at Johns Hopkins University. He currently resides in Manhattan, with his wife, Kristin, and his four children.